Gabapentin Capsule
Product Images NDC 82804-178

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82804-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing pain score over time compared to placebo.*

FDA Label Image

Figure 2 (Image 02)

A line graph depicting mean pain scores over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline through 7 weeks, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing results from two studies. The vertical axis represents percentage responders from 0% to 100%. Study 1 compares placebo (PBO) at 12% to Gabapentin (GBP) 3600 mg at 29%. Study 2 compares placebo at 14% to Gabapentin 1800 mg at 32% and Gabapentin 2400 mg at 34%, with significance markers indicating statistical differences.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine level, and a factor for female patients. It is a text panel illustrating a pharmacokinetic calculation relevant to drug dosing considerations.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin showing a cyclohexane ring bonded to a carbon with both amine (CH2NH2) and carboxylic acid (CH2CO2H) functional groups.*

FDA Label Image

82804-178-90 (Image 06)

Label for Gabapentin 100 mg capsules, 90 count, by Proficient Rx LP. The label includes dosage form and strength, storage instructions (20°-25°C), and identifies each capsule as containing 100 mg of gabapentin, USP. Imprints on capsules are described, and the manufacturer is ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

Image-09 (Image 09)

A scatter plot showing the percentage difference on the y-axis versus daily dose in milligrams on the x-axis. The graph compares results from three studies labeled as Study a, Study b, and Study c, with data points at daily doses of approximately 600, 900, 1200, and 1800 mg. Each study is represented by different square markers in black, gray, and white.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.